Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency

NCT02789397 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding for study.

Conditions

Granulomatous and Lymphocytic Interstitial Lung Disease

Interventions

DRUG: Rituximab (RTX) and Azathioprine (AZA)
DRUG: Placebos

Sponsor

Medical College of Wisconsin